In this study, organoids and FGFR2 fusion proteins were used to understand biliary tumorigenesis and solve the problem of lack of available gene signature defined ICC models in current preclinical research [108]. This evidence concerns the gene FGFR2 and intrahepatic cholangiocarcinoma.